Skip to main content
. 2013 Jun 3;28(6):814–820. doi: 10.3346/jkms.2013.28.6.814

Fig. 2.

Fig. 2

Screening rates of diabetic retinopathy and nephropathy. (A) Diabetic retinopathy screening rates are 38.1% (SE 5.5) in Korea National Health and Nutrition Examination Survey 2005 (KNHANES III) and 36.9% (SE 5.8) in KNHANES IV. Diabetic nephropathy screening rates are 50.4% (SE 5.3) in KNHANES III and 41.2% (SE 5.8) in KNHANES IV. (B) The averages of diabetic retinopathy screening rates were 38.1% (SE 5.5) in 2005, 41.7% (SE 14.2) in 2007, 35.2% (SE 9.4) in 2008, and 36.7% (SE 8.8) in 2009. In terms of diabetic nephropathy screening, the rates were 42.9% (SE 14.4) in 2007, 38.3% (SE 9.3), and 43.2% (SE 8.6) in 2009. The Korea Composite Stock Price Index (KOSPI) goes parallel with the diabetic retinopathy and nephropathy screening rates. (C) The averages of diabetic retinopathy screening rates in the United States were 54.8 in 2005, 54.6 in 2006, 55.0 in 2007, 56.5 in 2008, and 56.5 in 2009. The averages of diabetic nephropathy screening rates were 55.1 in 2005, 79.7 in 2006, 80.6 in 2007, 82.4 in 2008, and 82.9 in 2009. The Dow Jones Industrial Average (DJIA) decreased after 2007, but both diabetic retinopathy and nephropathy screening rates gradually increased.